You have 9 free searches left this month | for more free features.

osi-906

Showing 1 - 12 of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumors Trial in United Kingdom, United States (OSI-906, erlotinib)

Completed
  • Advanced Solid Tumors
  • Aurora, Colorado
  • +3 more
Nov 14, 2019

Advanced Solid Tumors, Pharmacokinetics of 14C-OSI-906 Trial in Tacoma (radio-labeled OSI-906, OSI-906)

Completed
  • Advanced Solid Tumors
  • Pharmacokinetics of 14C-OSI-906
  • radio-labeled OSI-906
  • OSI-906
  • Tacoma, Washington
  • +1 more
Feb 14, 2019

Ovarian Cancer, Solid Tumors Trial in Worldwide (OSI-906, Paclitaxel)

Completed
  • Ovarian Cancer
  • Solid Tumors
  • Scottsdale, Arizona
  • +45 more
Nov 14, 2019

Advanced Solid Tumors Trial in Houston, Sutton (OSI-906)

Completed
  • Advanced Solid Tumors
  • OSI-906
  • Houston, Texas
  • +1 more
Jan 29, 2019

Advanced Solid Tumors Trial in Nashville, Glasgow (OSI-906)

Completed
  • Advanced Solid Tumors
  • OSI-906
  • Nashville, Tennessee
  • +1 more
Jan 10, 2019

NSCLC, Non Small Cell Lung Cancer Trial in Worldwide (OSI-906, Erlotinib, Placebo)

Completed
  • NSCLC
  • Non Small Cell Lung Cancer
  • OSI-906
  • +2 more
  • La Jolla, California
  • +28 more
Jan 21, 2019

Adrenocortical Carcinoma Trial in Worldwide (OSI-906, Placebo)

Completed
  • Adrenocortical Carcinoma
  • OSI-906
  • Placebo
  • Scottsdale, Arizona
  • +34 more
Aug 31, 2018

Advanced Hepatocellular Carcinoma (HCC) Trial in Worldwide (OSI-906, Placebo)

Terminated
  • Advanced Hepatocellular Carcinoma (HCC)
  • OSI-906
  • Placebo
  • Los Angeles, California
  • +40 more
Aug 31, 2018

NSCLC (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemo Trial in Worldwide (OSI-906, erlotinib, )

Completed
  • Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
  • OSI-906
  • +2 more
  • Jacksonville, Florida
  • +68 more
Aug 31, 2018

Colorectal Cancer Trial in Aurora (OSI-906, irinotecan)

Terminated
  • Colorectal Cancer
  • Aurora, Colorado
    University of Colorado Denver
Oct 18, 2013

Head Neck Cancer Trial (Cetuximab, OSI-906, Placebo)

Withdrawn
  • Head and Neck Cancer
  • (no location specified)
Apr 4, 2013

Hormone-sensitive Metastatic Breast Cancer Trial in Franklin, Nashville (OSI-906, Erlotinib, Letrozole)

Terminated
  • Hormone-sensitive Metastatic Breast Cancer
  • OSI-906
  • +3 more
  • Franklin, Tennessee
  • +2 more
Aug 10, 2012